Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab (vol 3, pg 980, 2019)

被引：0
|
作者：
Lai, C.
Ranpura, V
Wu, C.
机构：
来源：
BLOOD ADVANCES | 2019年 / 3卷 / 11期
关键词：
D O I：
10.1182/bloodadvances.2019000319
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1657 / 1657
页数：1
相关论文
共 50 条
  • [1] Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab
    Lai, Catherine
    Ranpura, Vishal
    Wu, Colin
    Olnes, Matthew J.
    Parikh, Ankur R.
    Shenoy, Aarthi
    Thompson, Julie
    Weinstein, Barbara
    Scheinberg, Phillip
    Barrett, A. John
    Desmond, Ronan
    Young, Neal S.
    Hourigan, Christopher S.
    [J]. BLOOD ADVANCES, 2019, 3 (07) : 980 - 983
  • [2] Functional brain networks in never-treated and treated long-term Ill schizophrenia patients (vol 44, pg 1940, 2019)
    Yao, Li
    Li, Fei
    Liu, Jieke
    Liao, Wei
    Li, Xiaojing
    Li, Mingli
    Meng, Yajing
    Liang, Sugai
    Zhang, Chengcheng
    Yang, Xiao
    Wang, Qiang
    Ma, Xiaohong
    Guo, Wanjun
    Sweeney, John A.
    Gong, Qiyong
    Lui, Su
    Deng, Wei
    Li, Tao
    [J]. NEUROPSYCHOPHARMACOLOGY, 2020, 45 (08) : 1406 - 1406
  • [3] Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome
    Potter, Victoria T.
    Krishnamurthy, Pramila
    Barber, Linda D.
    Lim, ZiYi
    Kenyon, Michelle
    Ireland, Robin M.
    de Lavallade, Hugues
    Dhouri, Abdel
    Marsh, Judith C. W.
    Marcus, Robert
    Devereux, Stephen
    Ho, Aloysius
    Pagliuca, Antonio
    Mufti, Ghulam J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (01) : 111 - 117
  • [4] Long-term outcomes in patients with Takotsubo syndrome
    Imamura, Teruhiko
    [J]. IJC HEART & VASCULATURE, 2021, 35
  • [5] LONG-TERM OUTCOMES OF PATIENTS TREATED FOR TESTICULAR CANCER
    Havranek, O.
    Krhut, J.
    Nemec, D.
    Feltl, D.
    Hajek, J.
    Cvek, J.
    Dusek, L.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 640 - 640
  • [6] Long-term outcomes in patients with treated childhood hydrocephalus
    Gupta, Nalin
    Park, Jeanna
    Solomon, Cynthia
    Kranz, Dory A.
    Wrensch, Margaret
    Wu, Yvonne W.
    [J]. JOURNAL OF NEUROSURGERY, 2007, 106 (05) : 334 - 339
  • [7] Long-Term Follow-Up of Patients With Hypereosinophilic Syndrome Treated With Alemtuzumab, an Anti-CD52 Antibody
    Strati, Paolo
    Cortes, Jorge
    Faderl, Stefan
    Kantarjian, Hagop
    Verstovsek, Srdan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (03): : 287 - 291
  • [8] MODELLING THE LONG-TERM SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) DEL (5Q) TREATED WITH LENALIDOMIDE
    Benettaib, B.
    Lee, D.
    Dhanasiri, S.
    Brereton, N.
    [J]. HAEMATOLOGICA, 2013, 98 : 310 - 310
  • [9] Long-Term Outcomes after Alemtuzumab Induction in Lung Transplantation
    Shyu, S.
    Dew, M. A.
    Dabbs, A. De Vito
    Crespo, M.
    Zaldonts, D. B.
    Johnson, B. A.
    Studer, S. M.
    Toyoda, Y.
    Bermudez, C. A.
    Hattler, B. G.
    Pilewski, J. M.
    McCurry, K. R.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S68 - S68
  • [10] Long-Term Outcomes of Alemtuzumab Induction in Pediatric Kidney Transplantation
    Engen, R. M.
    Bartosh, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1152 - S1153
12345